Using Herd Immunity Excuse for Gene Therapy Vaccine on Kids by Dr. Joseph Mercola for Mercola
In children and young adults from age birth to 19, the survival rate of COVID-19 is 99.997%.1,2 In most cases, symptoms are mild or nonexistent. Among children who were hospitalized, 0.19% of children died from COVID-19, with researchers concluding in a 2021 study, “Hospitalization and in-hospital death are rare in children diagnosed with COVID-19.”3
Despite the fact that COVID-19 has had little impact, physically, to children, health officials are setting the stage for widespread vaccination of this population. The University of Oxford, which is collaborating on a COVID-19 vaccine with AstraZeneca, is already enrolling children between the ages of 6 years and 17 years and 8 months in their U.K. vaccine trial.4
A COVID vaccine for infants and children is every bit as unnecessary, dangerous and foolish as the hepatitis B vaccine is for infants that I have been railing against for the past two decades.
Now is your chance to support Gospel News Network.
We love helping others and believe that’s one of the reasons we are chosen as Ambassadors of the Kingdom, to serve God’s children. We look to the Greatest Commandment as our Powering force.
Moderna is also enrolling 3,000 children between the ages of 12 and 17 to test their COVID-19 vaccine, using the same dose given to adults,5 while Pfizer also expanded its clinical trials to include children as young as 12.6 Johnson & Johnson even announced on February 28, 2021, that it plans to test its COVID-19 vaccine on infants, including newborn babies, pregnant women and people with compromised immune systems.
“They did not get into a lot of detail about it but did make it clear they will be pursuing pediatric and maternal coronavirus immunization studies,” Dr. Ofer Levy, a member of the FDA’s advisory committee who reviewed Johnson & Johnson’s vaccine data, told The New York Times.7
It’s Gene Therapy — Not a Vaccine
The COVID-19 vaccine really isn’t a vaccine in the medical definition of a vaccine. It’s more accurately an experimental gene therapy, of which the effectiveness and safety are far from proven. During the first six weeks the vaccine was available, more than 500 post-vaccination deaths and nearly 11,000 other adverse events were reported to the U.S. Vaccine Adverse Event Reporting System (VAERS).8
According to Children’s Health Defense (CHD), professor Dolores J. Cahill, Ph.D., a molecular biologist and immunologist, “expects to see successive waves of adverse reactions to the experimental messenger RNA (mRNA) injections ranging from anaphylaxis and other allergic responses to autoimmunity, sepsis and organ failure.”9
Considering that children are at extremely low risk from COVID-19, vaccination offers them far more risk than benefit, and parents may be understandably reluctant to volunteer their children to receive this experimental and unlicensed gene therapy. Public health officials have made it clear, however, that vaccination of children is expected. CHD reported:10
“Already last April — when next to nothing was known about COVID’s epidemiology, and candidate vaccines had barely begun to be studied — Bill Gates set the stage for the pediatric push, declaring that the end goal is to make COVID-19 vaccines ‘part of the routine newborn immunization schedule.’”
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), also stated that 85% to 90% of the U.S. population, including children, will need to receive a COVID-19 vaccine before life can return to normal, and he suggested that first graders may be authorized to be vaccinated by September 2021.11
